Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of ...

A groundbreaking medication designed to delay the onset of Alzheimer's has received approval for use within the EU. The drug, ...

In today’s fast-paced world, maintaining optimal cognitive function is more important than ever. Whether you’re a student ...

In today’s fast-paced world, the need for cognitive enhancement has never been greater. Maintaining optimal brain function is essential for success as we navigate through our daily responsibilities, ...

The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus ...

Researchers have discovered that the NMDA receptor (NMDAR), known for its role in learning and memory, also stabilizes brain activity by setting baseline neural network activity.

A drug used to treat glaucoma holds promise in the fight against various forms of dementia, according to University of ...

"Luckily, engaging in 20 minutes of moderate exercise has been proven to offset the effects of a poor night of sleep. This ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the ...

New scientific research on how the brain maintains stability amidst continuous environmental and physiological changes offers ...